The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Psychiatry
Sec. Anxiety and Stress Disorders
Volume 15 - 2024 |
doi: 10.3389/fpsyt.2024.1514428
Development of Anxiety Symptoms After Receiving the Pfizer-BioNTech (BNT 162b2) COVID-19 Vaccine: A Case Series
Provisionally accepted- 1 Riga Stradiņš University, Riga, Latvia
- 2 Department of Psychosomatic Medicine and Psychotherapy, Riga, Latvia
COVID infection can result in long-term health consequences i.e., long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. Less studied, however, are the links between vaccination and psychiatric disorders. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer BioNTech BNT 162b2 vaccine. It is important to explore the relationship between anxiety and other mental health disorders and COVID-19 vaccination and investigate potential pathogenetic mechanisms.
Keywords: COVID-19 vaccines, SARS-CoV-2 vaccine, BioNTech162 Vaccine, Anxiety, case reports
Received: 20 Oct 2024; Accepted: 26 Dec 2024.
Copyright: © 2024 Taube and Lesiņa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Māris Taube, Riga Stradiņš University, Riga, Latvia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.